Cell Transfection Market Industry Outlook 2026–2030 Highlighting Growth Momentum And Market Trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Cell Transfection Market Change Between 2026 And 2030?

The market for cell viability assays has expanded significantly in recent years. It is projected to grow from $1.73 billion in 2025 to $1.91 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.5%. Historically, this expansion has been driven by factors such as the increasing scope of in vitro research activities, greater spending on pharmaceutical R&D, an uptick in toxicology testing, the growing adoption of cell culture models, and the widespread availability of standardized assay kits.

The cell viability assays market size is projected to experience substantial growth over the next few years. It is anticipated to reach $2.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period is primarily driven by factors such as the increasing need for high-throughput drug discovery, the rising use of automated assay platforms, the broadening scope of personalized medicine research, an intensifying focus on assay miniaturization, and the growing incorporation of imaging-based viability analysis. Key trends expected within this period involve the increasing uptake of high-sensitivity viability assays, a growing reliance on microplate-based detection systems, an expanding requirement for multiparametric cell health analysis, the proliferation of drug screening applications, and an elevated emphasis on reproducible assay protocols.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Which Growth Factors Are Strengthening The Cell Transfection Market Landscape?

The rising prevalence of cell-based therapeutics is projected to fuel the expansion of the cell viability assay market moving forward. Cell-based therapeutics refer to medical interventions that utilize living cells to repair or replace damaged tissue, address diseases, or restore normal functionality. The advancement of these therapeutics is propelled by breakthroughs in biotechnology, increased investment in regenerative medicine, growing acceptance and adoption of cell therapies, and improvements in cell engineering and manufacturing technologies. Cell viability assays are vital for supporting cell-based therapeutics by ensuring the health, functionality, and safety of the therapeutic cells, thereby optimizing treatment efficacy and quality control. For instance, in 2023, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the number of gene therapies in Phase III clinical trials experienced a 10% increase in Q3 2023, marking the first quarterly rise since Q3 2022. Therefore, the growth in cell-based therapeutics is significantly driving the cell viability assay market’s growth.

Which Segment Groups Define The Cell Transfection Market Landscape?

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

What Trends Are Influencing The Cell Transfection Market Outlook?

Leading companies in the cell viability assays market are developing innovative cell screening technologies to improve accuracy and speed up drug discovery. These cell screening technologies enhance cell viability assays by enabling high-throughput, precise, and rapid analysis of cell health and responses, thereby optimizing experimental conditions and improving the development of therapeutic strategies. For instance, in May 2024, Arralyze, a Germany-based technology company, introduced CellShepherd, a cutting-edge platform designed for single-cell analysis. It utilizes proprietary nanowell glass arrays to miniaturize cell-based assays for real-time monitoring. The autonomous system offers precise cell dispensing, co-culturing in sterile conditions, and imaging capabilities with both brightfield and fluorescent channels. Its AI-driven analysis guarantees accurate cell counting and tracking. This user-friendly platform addresses the increasing need for precise single-cell research across biomedical and life science applications.

Who Are The Businesses Driving Activity In The Cell Transfection Market?

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Access The Complete Cell Transfection Market Report:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

Which Region Has The Strongest Presence In The Cell Transfection Market?

North America was the largest region in the cell transfection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cell Transfection Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=19361&type=smp

Browse Through More Reports Similar to the Global Cell Transfection Market 2026, By The Business Research Company

Cells Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Human Raw Materials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

Stem Cells Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795